Form 8-K - Current report:
SEC Accession No. 0001193125-18-242792
Filing Date
2018-08-08
Accepted
2018-08-08 16:25:58
Documents
3
Period of Report
2018-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d597946d8k.htm 8-K 15552
2 EX-99.1 d597946dex991.htm EX-99.1 44004
3 GRAPHIC g597946sangamologo.jpg GRAPHIC 11503
  Complete submission text file 0001193125-18-242792.txt   76833
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 181001734
SIC: 2836 Biological Products, (No Diagnostic Substances)